Skip to content

Effect of alendronate on dental implant integration and crestal bone level

Effect of Alendronate on Endosseous Implant Integration and Crestal Bone Level: A Randomized Controlled Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100680
Enrollment
64
Registered
2026-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Alendronate Solution: Dose- 0.2 ml Concentration- 75 mg Alendronate in 100 ml Distilled water Frequency- once applied during implant placement. Route of administration- applied locally

Sponsors

Dr Raghvendra Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Bilateral nearly symmetrical edentulous site, Two Edentulous site with at least one natural tooth in between, Sufficient alveolar bone at the site, Systemically healthy patients, No acute infection.

Exclusion criteria

Exclusion criteria: Medically compromised patients, Poor bone quality or volume, Para functional habits, Habit of smoking, alcohol intake or drug abuse, Pregnant woman and lactating mother.

Design outcomes

Primary

MeasureTime frame
Intra oral periapical radiograph (IOPAR) /Cone beam computed tomography (CBCT) will be taken to assess the crestal bone level (from platform of implant till bone level, first implant bone interface)Timepoint: (1) Baseline- On the day of surgery immediately after implant placement (2) At implant loading, 4 to 6 months from implant placement (3) After 3 months from implant loading

Secondary

MeasureTime frame
Plaque Index (PI)Timepoint: These clinical parameters will be collected pre and post operatively- (1) Baseline- On the day of surgery before implant placement (2) At implant loading, after 4-6 month from implant placement (3) After 3 months from implant loading.;Gingival Index (GI)Timepoint: These clinical parameters will be collected pre and post operatively- (1) Baseline- On the day of surgery before implant placement (2) At implant loading, after 4-6 month from implant placement (3) After 3 months from implant loading.;Peri- Implant Probing Pocket Depth (PIPPD) - This assessment will be done post operatively at 4 sites around implant (Mesio- Buccal, Buccal, Disto- Buccal, Palatal)Timepoint: (1) Baseline- At implant loading, after 4-6 month from implant placement (2) After 3 months from implant loading.;Implant Stability - This assessment will be Resonance Frequency Analysis (RFA) done intra and post operatively using Osstell device in Implant Stability Quotient (ISQ) valueTimepoint: (1) Baseline- On the day of surgery immediately after implant placement (2) At implant loading, after 4 to 6 months from implant placement (3) After 3 months from implant loading.;Peri-Implant Crevicular Fluid (PICF) sample collected by Periopaper strips and analyzed for Cathepsin K (CatK) and Osteocalcin (OC) levels using Enzyme- Linked Immunosorbent Assay (ELISA).Timepoint: These assessment will be done post operatively- (1) After 2 weeks from implant placement (2) After 4 weeks from implant placement (3) After 4 to 6 months from implant placement, at the time of implant loading (4) After 3 months from implant loading.

Countries

India

Contacts

Public ContactDr Raghvendra Gupta

Faculty of Dental Sciences, Uttar Pradesh University of Medical Sciences

dr.rkthakurperio@gmail.com9997060666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026